Cargando…

Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France

BACKGROUND: The purpose of this study was to compare cervical cancer screening by pap smear (PS) versus preliminary HPV testing based on self-collected samples (SC-HPV). METHODS: Interventional study among underprivileged women from 25 to 65 years old in four French cities. The control group (CG) wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Reques, Laura, Rolland, Camille, Lallemand, Anne, Lahmidi, Najat, Aranda-Fernández, Ezequiel, Lazzarino, Antonio, Bottero, Julie, Hamers, Françoise, Bergeron, Christine, Haguenoer, Ken, Launoy, Guy, Luhmann, Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157706/
https://www.ncbi.nlm.nih.gov/pubmed/34039341
http://dx.doi.org/10.1186/s12905-021-01356-8
_version_ 1783699741408755712
author Reques, Laura
Rolland, Camille
Lallemand, Anne
Lahmidi, Najat
Aranda-Fernández, Ezequiel
Lazzarino, Antonio
Bottero, Julie
Hamers, Françoise
Bergeron, Christine
Haguenoer, Ken
Launoy, Guy
Luhmann, Niklas
author_facet Reques, Laura
Rolland, Camille
Lallemand, Anne
Lahmidi, Najat
Aranda-Fernández, Ezequiel
Lazzarino, Antonio
Bottero, Julie
Hamers, Françoise
Bergeron, Christine
Haguenoer, Ken
Launoy, Guy
Luhmann, Niklas
author_sort Reques, Laura
collection PubMed
description BACKGROUND: The purpose of this study was to compare cervical cancer screening by pap smear (PS) versus preliminary HPV testing based on self-collected samples (SC-HPV). METHODS: Interventional study among underprivileged women from 25 to 65 years old in four French cities. The control group (CG) was referred for a PS. The experimental group (EG) conducted a SC-HPV test followed by a PS in case of positivity. Differences on screening completion and cytological abnormalities were analysed by logistic and Cox regression. RESULTS: 383 women were assigned to the EG and 304 to the CG. The screening completion proportion was 39.5% in the CG compared to 71.3% in the EG (HR = 2.48 (CI 95% [1.99–3.08]; p < 0.001). The proportion of cytological abnormalities was 2.0% in the CG and 2.3% in the EG (OR = 1.20 (CI 95% [0.42–3.40]; p = 0.7). The proportion of participants lost to follow-up was 60.5% in the CG and 63.2% in the EG HPV positive (p = 0.18). CONCLUSION: Providing an SC-HPV-test increased the participation of underprivileged women in CCS. Nevertheless, the significant number of lost to follow-up in both groups can undermine the initial benefits of the strategy for HPV positive women. Registration: Clinicaltrials.gov: NCT03118258.
format Online
Article
Text
id pubmed-8157706
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81577062021-05-28 Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France Reques, Laura Rolland, Camille Lallemand, Anne Lahmidi, Najat Aranda-Fernández, Ezequiel Lazzarino, Antonio Bottero, Julie Hamers, Françoise Bergeron, Christine Haguenoer, Ken Launoy, Guy Luhmann, Niklas BMC Womens Health Research Article BACKGROUND: The purpose of this study was to compare cervical cancer screening by pap smear (PS) versus preliminary HPV testing based on self-collected samples (SC-HPV). METHODS: Interventional study among underprivileged women from 25 to 65 years old in four French cities. The control group (CG) was referred for a PS. The experimental group (EG) conducted a SC-HPV test followed by a PS in case of positivity. Differences on screening completion and cytological abnormalities were analysed by logistic and Cox regression. RESULTS: 383 women were assigned to the EG and 304 to the CG. The screening completion proportion was 39.5% in the CG compared to 71.3% in the EG (HR = 2.48 (CI 95% [1.99–3.08]; p < 0.001). The proportion of cytological abnormalities was 2.0% in the CG and 2.3% in the EG (OR = 1.20 (CI 95% [0.42–3.40]; p = 0.7). The proportion of participants lost to follow-up was 60.5% in the CG and 63.2% in the EG HPV positive (p = 0.18). CONCLUSION: Providing an SC-HPV-test increased the participation of underprivileged women in CCS. Nevertheless, the significant number of lost to follow-up in both groups can undermine the initial benefits of the strategy for HPV positive women. Registration: Clinicaltrials.gov: NCT03118258. BioMed Central 2021-05-26 /pmc/articles/PMC8157706/ /pubmed/34039341 http://dx.doi.org/10.1186/s12905-021-01356-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Reques, Laura
Rolland, Camille
Lallemand, Anne
Lahmidi, Najat
Aranda-Fernández, Ezequiel
Lazzarino, Antonio
Bottero, Julie
Hamers, Françoise
Bergeron, Christine
Haguenoer, Ken
Launoy, Guy
Luhmann, Niklas
Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
title Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
title_full Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
title_fullStr Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
title_full_unstemmed Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
title_short Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
title_sort comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in france
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157706/
https://www.ncbi.nlm.nih.gov/pubmed/34039341
http://dx.doi.org/10.1186/s12905-021-01356-8
work_keys_str_mv AT requeslaura comparisonofcervicalcancerscreeningbyselfsamplingpapillomavirustestversuspapsmearinunderprivilegedwomeninfrance
AT rollandcamille comparisonofcervicalcancerscreeningbyselfsamplingpapillomavirustestversuspapsmearinunderprivilegedwomeninfrance
AT lallemandanne comparisonofcervicalcancerscreeningbyselfsamplingpapillomavirustestversuspapsmearinunderprivilegedwomeninfrance
AT lahmidinajat comparisonofcervicalcancerscreeningbyselfsamplingpapillomavirustestversuspapsmearinunderprivilegedwomeninfrance
AT arandafernandezezequiel comparisonofcervicalcancerscreeningbyselfsamplingpapillomavirustestversuspapsmearinunderprivilegedwomeninfrance
AT lazzarinoantonio comparisonofcervicalcancerscreeningbyselfsamplingpapillomavirustestversuspapsmearinunderprivilegedwomeninfrance
AT botterojulie comparisonofcervicalcancerscreeningbyselfsamplingpapillomavirustestversuspapsmearinunderprivilegedwomeninfrance
AT hamersfrancoise comparisonofcervicalcancerscreeningbyselfsamplingpapillomavirustestversuspapsmearinunderprivilegedwomeninfrance
AT bergeronchristine comparisonofcervicalcancerscreeningbyselfsamplingpapillomavirustestversuspapsmearinunderprivilegedwomeninfrance
AT haguenoerken comparisonofcervicalcancerscreeningbyselfsamplingpapillomavirustestversuspapsmearinunderprivilegedwomeninfrance
AT launoyguy comparisonofcervicalcancerscreeningbyselfsamplingpapillomavirustestversuspapsmearinunderprivilegedwomeninfrance
AT luhmannniklas comparisonofcervicalcancerscreeningbyselfsamplingpapillomavirustestversuspapsmearinunderprivilegedwomeninfrance